Author

Barbara Franceschini

IRCCS Humanitas Research HospitalORCID 0000-0001-6348-248XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Amaya López-PascualiD· 1 shared Ana LleòiD· 1 shared Borja Castelló-UribeiD· 1 shared Carmen BerasainiD· 1 shared Elena Adán-VillaescusaiD· 1 shared Emiliana Valbuena-GoiricelayaiD· 1 shared Eva SticováiD· 1 shared Flavio MilanaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amaya López-PascualORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Protein arginine-methyltransferase 1 (PRMT1): a new pharmacological target in cholangiocarcinoma

Emiliana Valbuena-Goiricelaya, Jasmin Elurbide, Maria Ujue Latasa, Amaya López-Pascual, Iker Uriarte, Leticia Colyn, Patrícia Inácio, Robert Arnes‐Benito, Elena Adán-Villaescusa, Borja Castelló-Uribe, Barbara Franceschini, Flavio Milana, Pavel Strnad, Soňa Fraňková, Eva Sticová, , Matias Antonio Avila

This study identifies PRMT1 as a critical driver of cholangiocarcinoma growth and immune evasion, showing its inhibition enhances antitumor immunity and synergizes with immunotherapy.

bioRxiv · May 29, 2026 · PreprintCancer Biology